Clinical Trial Results:
A randomized, double-blind, placebo-controlled, parallel group study to
evaluate the safety and efficacy of four weeks treatment of 7.5 mg
b.i.d, 15 mg q.d and 15 mg b.i.d. BIBW 2948 BS (inhalation powder,
hard capsule for Handihaler®) in patients with COPD associated with
chronic bronchitis.
Summary
|
|
EudraCT number |
2007-003742-15 |
Trial protocol |
FR |
Global completion date |
16 Sep 2008
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v2(current) |
This version publication date |
21 Apr 2019
|
First version publication date |
12 Nov 2016
|
Other versions |
v1 |
Version creation reason |
|
Summary report(s) |
Statement |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.